Literature DB >> 19482105

Evidence that proton-pump inhibitor therapy induces the symptoms it is used to treat.

Kenneth E L McColl, Derek Gillen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19482105     DOI： 10.1053/j.gastro.2009.05.015

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  12 in total

1.  Mechanism of acid hypersecretion post curative gastrinoma resection.

Authors:  Jeremiah V Ojeaburu; Tetsuhide Ito; Pellegrino Crafa; Cesare Bordi; Robert T Jensen
Journal:  Dig Dis Sci       Date:  2010-08-20       Impact factor: 3.199

2.  GERD: increased gastric acid secretion as a possible cause of GERD.

Authors:  Jerry D Gardner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-03       Impact factor: 46.802

3.  Randomised trial of the effect of a gastrin/CCK2 receptor antagonist on esomeprazole-induced hypergastrinaemia: evidence against rebound hyperacidity.

Authors:  Malcolm Boyce; Frans van den Berg; Toni Mitchell; Kate Darwin; Steve Warrington
Journal:  Eur J Clin Pharmacol       Date:  2016-10-29       Impact factor: 2.953

4.  Gastroesophageal reflux symptoms not responding to proton pump inhibitor: GERD, NERD, NARD, esophageal hypersensitivity or dyspepsia?

Authors:  Mohammad Bashashati; Reza A Hejazi; Christopher N Andrews; Martin A Storr
Journal:  Can J Gastroenterol Hepatol       Date:  2014-04-09

Review 5.  [Newly recognized side-effects of proton pump inhibitors. Arguments in favour of fundoplication for GERD?].

Authors:  B H A von Rahden; M Scheurlen; J Filser; H J Stein; C-T Germer
Journal:  Chirurg       Date:  2012-01       Impact factor: 0.955

6.  Predictors of Gastrin Elevation Following Proton Pump Inhibitor Therapy.

Authors:  Hólmfridur Helgadóttir; Sigrún H Lund; Sveinbjörn Gizurarson; David C Metz; Einar S Björnsson
Journal:  J Clin Gastroenterol       Date:  2020-03       Impact factor: 3.062

7.  LINX(®) Reflux Management System in chronic gastroesophageal reflux: a novel effective technology for restoring the natural barrier to reflux.

Authors:  Luigi Bonavina; Greta Saino; John C Lipham; Tom R Demeester
Journal:  Therap Adv Gastroenterol       Date:  2013-07       Impact factor: 4.409

8.  The type 2 CCK/gastrin receptor antagonist YF476 acutely prevents NSAID-induced gastric ulceration while increasing iNOS expression.

Authors:  Dominic-Luc Webb; Tobias Rudholm-Feldreich; Linda Gillberg; Md Abdul Halim; Elvar Theodorsson; Gareth J Sanger; Colin A Campbell; Malcolm Boyce; Erik Näslund; Per M Hellström
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-11-24       Impact factor: 3.000

9.  Healing and Antisecretory Effects of Aqueous Extract of Eremomastax speciosa (Acanthaceae) on Unhealed Gastric Ulcers.

Authors:  A P Amang; C Mezui; G T Siwe; J Emakoua; G Mbah; E Z Nkwengoua; G E Enow-Orock; P V Tan
Journal:  Biomed Res Int       Date:  2017-10-19       Impact factor: 3.411

10.  Magnetic sphincter augmentation (MSA) in patients with hiatal hernia: clinical outcome and patterns of recurrence.

Authors:  Shahin Ayazi; Nobel Chowdhury; Ali H Zaidi; Kristy Chovanec; Yoshihiro Komatsu; Ashten N Omstead; Ping Zheng; Toshitaka Hoppo; Blair A Jobe
Journal:  Surg Endosc       Date:  2019-07-08       Impact factor: 4.584
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.